UBS Group’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33K Buy
+204
New +$3.92K ﹤0.01% 9367
2026
Q1
Sell
-4
Closed -$190 10374
2025
Q4
$165 Sell
4
-143
-97% -$20.1K ﹤0.01% 10135
2025
Q3
$27.4K Buy
147
+28
+24% +$7.05K ﹤0.01% 7955
2025
Q2
$29.9K Buy
119
+80
+205% +$24.4K ﹤0.01% 8161
2025
Q1
$10.5K Buy
39
+33
+550% +$18.3K ﹤0.01% 8626
2024
Q4
$5.7K Sell
6
-45
-88% -$59K ﹤0.01% 8626
2024
Q3
$20.4K Buy
+51
New +$63K ﹤0.01% 7364
2024
Q2
Sell
-1
Closed -$2.69K 9098
2024
Q1
$1.76K Hold
1
﹤0.01% 8054
2023
Q4
$9.92K Buy
+1
New +$11.5K ﹤0.01% 7463
2023
Q3
Hold
0
7211
2023
Q2
Hold
0
7199
2023
Q1
Sell
-4
Closed -$226K 7597
2022
Q4
$233K Sell
4
-2
-33% -$113K ﹤0.01% 5340
2022
Q3
$395K Hold
6
﹤0.01% 4544
2022
Q2
$378K Hold
6
﹤0.01% 4472
2022
Q1
$615K Hold
6
﹤0.01% 4545
2021
Q4
$360K Hold
6
﹤0.01% 5238
2021
Q3
$723K Buy
6
+3
+100% +$388K ﹤0.01% 4460
2021
Q2
$380K Hold
3
﹤0.01% 4918
2021
Q1
$488K Buy
3
+2
+200% +$439K ﹤0.01% 4884
2020
Q4
$257K Buy
+1
New +$155K ﹤0.01% 5084
2020
Q3
Hold
0
6580
2020
Q2
Hold
0
6223
2020
Q1
Hold
0
6720
2019
Q4
Hold
0
7659
2019
Q3
Hold
0
-$4K 8095
2019
Q2
Hold
0
7451
2019
Q1
Hold
0
7440
2018
Q4
Hold
0
7545
2018
Q3
Hold
0
7208
2018
Q2
Hold
0
7405

Other funds holding GNPX

UBS Group's GNPX Position: Q2 2026 in Review

UBS Group opened a new position in Genprex (GNPX) in Q2 2026: 204 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #9367 among its holdings. This is a return to the name: UBS Group previously reported a position in GNPX as recently as Q4 2025.

UBS Group first reported a position in GNPX in Q4 2020 and has held it in 18 quarters since. The position peaked at $723K in Q3 2021. 11 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • UBS Group held 204 shares of Genprex worth $2.33K as of Q2 2026.
  • Genprex was a new UBS Group position in Q2 2026.
  • Genprex made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9367 holding.
  • UBS Group first reported a position in Genprex in Q4 2020 and has held it in 18 quarters since.
  • UBS Group's Genprex position peaked at $723K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.